Contact
Please use this form to send email to PR contact of this press release:
Opthea Completes Successful Meetings with FDA and EMA for OPT-302 Phase 3 Clinical Program in Wet AMD
TO:
Please use this form to send email to PR contact of this press release:
Opthea Completes Successful Meetings with FDA and EMA for OPT-302 Phase 3 Clinical Program in Wet AMD
TO: